Maven Securities’s Apollo Endosurgery, Inc. APEN Stock Holding History

Maven Securities’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-58,500	Closed	-$580K	–	1106
2023 Q1	$580K	Buy	58,500 +14,749	+34%	+$146K	0.01%	614
2022 Q4	$436K	Buy	+43,751	New	+$326K	0.01%	607

Maven Securities's APEN Position: Q2 2023 in Review

Maven Securities sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 58,500 shares — an estimated $580K sold.

Maven Securities first reported a position in APEN in Q4 2022 and held it in 2 quarters. The position peaked at $580K in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Maven Securities reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Maven Securities sold 58,500 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $580K.
Maven Securities first reported a position in Apollo Endosurgery, Inc. in Q4 2022 and held it in 2 quarters.
Maven Securities's Apollo Endosurgery, Inc. position peaked at $580K in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Maven Securities's 13F filing for Q2 2023, filed 4 Aug 2023.